Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization

Clinical trial NCT05308030 · UNKNOWN

Trial details

NCT number: NCT05308030
Sponsor: Assiut University
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Peripheral Arterial Disease

Start date: 2022-08-01
Primary completion: 2023-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.